Introduction
In biological systems asymmetry and optical activity are widely distributed, as illustrated by sugars, proteins, enzymes and receptors. Thus it is to be expected that chiral drugs and metabolites having stereogenic centres interact stereospecifically with biological systems. In fact, enantiomers are often handled differently during the processes of absorption, distribution, metabolism and elimination from the body.
In the simplest case of a chiral drug with a single stereogenic centre, if the main pharmacological activity resides in one enantiomer, there are a number of options for the biological activity of the second enintiomer. Thus it may display: qualitatively similar pharmacological activity, but a lower quantitative potency; no pharmacological activity; qualitatively different pharmacological activity, which may be beneficial or undesirable; a synergistic or antagonistic effect on the activity of the active isomer; or it may possess a greater toxicity than the active isomer.
Consequently there is increasing pressure to prepare enantiomers by commercially acceptable routes, for example by stereoselective synthesis, or by large-scale chromatography. In this context the new generation of chiral separation technology plays an essential role in pharmaceutical quality assurance in establishing an acceptable level of chiral purity. Moreover, in bioanalytical studies, chiral separations are essential to permit individual drug enantiomers to be monitored in studies on chiral metabolism, chiral pharmacokinetics and pharmacodynamics.
Chiral liquid chromatography
Since enantiomers have identical bulk chemical properties, they cannot be resolved by conventional separation techniques. There are three methods for resolving enantiomers by liquid chromatography: two exploit conventional column technology, either by formation of diastereomeric derivatives or by the use of chiral mobile-phase additives; the third involves the use of a chiral stationary phase (CSP).
Abbreviations used: CSP, chiral stationary phase; ODS, octadecylsilane; AGP, a ,-glycoprotein.
Diastereoisomer formotion
Diastereoisomer formation involves reacting a pair of enantiomers with an optically pure chiral reagent to form the corresponding pair of diastereoisomeric derivatives. These differ in their physical properties and can thus be resolved by conventional reversedphase liquid chromatography. The main disadvantages of this approach are the possibility of interference introduced by impurities in the reagent, or of the enantiomers reacting at different rates with the derivatizing reagent, leading to incorrect values for the enantiomer ratio. However, this method has been widely used in drug development with some notable success [ 1,2].
Chiral mobile-phase additives
To resolve a chiral compound requires a threepoint interaction between the analyte and a chiral The wider rim consists of secondary hydroxyl groups, the other comprising of primary hydroxyl groups, while the inner ,surface is primarily hydrophobic. The recognition model is considered to rely on inclusion of a bulky hydrophobic group into the cyclodextrin cavity, while other groups on or close to the stereogenic centre are postulated to interact with the secondary hydroxyl groups on the outer rim [7] .
The recognition model for cyclodextrin in the mobile phase is more complex than that for cyclodextrin used as a bonded stationary phase, because the whole of the cyclodextrin molecule can interact with the analyte, allowing multiple cyclodextrinanalyte interactions. In fact, some separations based on the use of cyclodextrins added to the mobile phase are not practicable when the same cyclodextrin is used as a stationary phase and vice-versa.
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Chirality and Drug Development Chiral ion-pairing as pioneered by Pettersson & Schill [8] involves the association of charged enantiomers of the chiral analyte with an oppositely charged pure chiral counter-ion, to form electrically neutral ion-pairs as transient diastereomers. These diastereomeric ion-pairs display different physical properties, and can therefore be separated in the normal-phase mode, where the presence of a small amount of water has been found to be critical for the formation of stable ion-pairs [8] . Although this method is well described theoretically, it remains essentially a research technique, albeit with significant potential. The Pirkle phases are by far the most widely characterized in the literature [ 113. However, derivatization of the analyte is often required to provide the necessary three interaction sites with the CSP. Acid and amine groups in particular usually need to be derivatized. Moreover, the Pirkle columns require an aprotic environment and this means that a biological sample must first be extracted from the aqueous matrix and transferred to a suitable organic solvent.
CSPS
The second and third types of stationary phases comprise various derivatives of cellulose. For these phases it is considered that an important part of the chiral recognition mechanism involves the formation of attractive interactions between the solute and the CSP, with part of the solute molecule entering a cavity or ravine within the structure of the stationary phase [12] . For example, microcrystalline triacetyl cellulose (classified by Wainer as type 3) has a high degree of cross-linking in the cellulose and this gives possibilities for inclusion complexation [13] . The most common of the commercially available inclusion-type CSPs are the cyclodextrin phases developed by Armstrong et at! [7] . These are based on a-, p-, acetylated-p-or ycyclodextrin, bonded to silica and operated in reversed-phase mode. In this type of phase the cyclodextrin molecules are bonded to the silica support via a hydrocarbon linkage, and function as described above. These have proved to be a popular and reasonably successful means for practical chiral analysis.
The fourth category is based on chiral ligandexchange chromatography, developed by Davankov in the early 1970s, and based on an achiral h.p.1.c. support, such as ODs-silica, with a chiral mobile phase containing a transition-metal ion, such as Cu2+, together with a single enantiomer of an amino acid such as L-proline [ 141. The resolution of an enantiomeric solute occurs due to the formation of a diastereomeric mixed-chelate complex. Ligandexchange systems have been used almost exclusively to resolve amino acids.
The fifth category of CSP is based on protein as a chiral selector bonded to a silica support. There are three types of protein-bonded phase commercially available: one based on bovine serum albumin [171.
Chiroptical detection
The recent availability of commercial, laser-based polarimetric detectors may open the field for determination of enantiomer ratios using U.V. and polarimetric detection in series. If these detectors are connected to a CSP, the enantiomeric purity can be calculated even where there is a significant degree of peak overlap [ 181. If an achiral column is used and the pure enantiomers are available for calibration, the chemical and enantiomeric purity of a drug can, in principle, be assessed without resolution ~9 1 .
Conclusion
Since more than 40 CSPs are currently available, together with a number of chiral mobile phase additives, the options for chiral chromatography are very wide. However, the likelihood that a universal CSP will be discovered is remote. Indeed one of the biggest problems is in understanding the fundamental mechanisms involved and predicting the CSP to be used for specific problems. Although Pirkle phases and cyclodextrin phases offer the best rationale for use, in general most decisions are based on empirical experiments, with a degree of justification post fact0 in terms of the proposed mechanism involved. The protein columns based on AGP and ovomucoid have shown the widest range of applicability so far, although the mechanisms of chiral recognition on these phases are by no means fully understood.
